Evidence map›Paper›PMID 31699114›Full record

ArticleDiagnostic pathology2019

Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics.

Martin Hysek, Kenbugul Jatta, Adam Stenman, Eva Darai-Ramqvist, Jan Zedenius, Anders Höög, C Christofer Juhlin

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Martin HysekDepartment of Oncology-Pathology, BioClinicum J6:20, Karolinska Institutet, 171 64, Stockholm, Sweden.
Kenbugul JattaDepartment of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
Adam StenmanDepartment of Oncology-Pathology, BioClinicum J6:20, Karolinska Institutet, 171 64, Stockholm, Sweden.
Eva Darai-RamqvistDepartment of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
Jan ZedeniusDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Anders HöögDepartment of Oncology-Pathology, BioClinicum J6:20, Karolinska Institutet, 171 64, Stockholm, Sweden.
C Christofer JuhlinDepartment of Oncology-Pathology, BioClinicum J6:20, Karolinska Institutet, 171 64, Stockholm, Sweden. christofer.juhlin@ki.se.ORCID http://orcid.org/0000-0002-5945-9081
Karolinska University Hospital · SE

Funding

Cancerfonden Junior Clinical Investigator AwardSvenska Sällskapet för Medicinsk Forskning Stora Etableringsanslaget
6 · The paper itself

Abstract

backgroundFollicular thyroid carcinoma (FTC) is a neoplasm that presents with a micro-follicular growth pattern and a neutrally stained cytoplasm. Seldom, FTCs display unusual morphological characteristics - but given the rarity of these histological subtypes, little is known regarding the underlying genetics and the coupling to patient outcome. CASE PRESENTATION: We present two extremely rare cases of minimally invasive FTC with signet ring cell morphology (SRC-FTC) and describe the cytological, microscopic, immunohistochemical and molecular features for both tumors. Both were male patients, age 71 and 51 respectively. The preoperative cytology for both cases could not pinpoint a clear-cut signet ring cell morphology, but a tendency towards nuclear marginalization was seen. The tumors were 38 mm and 22 mm respectively and displayed evident signet ring cell features in subsets of tumor cells as well as degenerative stromal changes. The tumor cells were positive for TTF1, PAX8 and thyroglobulin, and the proliferation indexes were 4% and 1,9% respectively. Both tumors displayed capsular invasion, but not lymphovascular invasion. The tumors were sequenced for mutations in the TERT promoter and 22 additional cancer-related genes, interestingly; one patient was shown to carry a deleterious intronic variant in PTEN, a tumor suppressor gene coupled to thyroid tumorigenesis and Cowden syndrome. Both patients are alive and well awaiting postoperative radioiodine treatment.

conclusionsThe SRC-FTCs described herein were small, TERT promoter wildtype tumors exhibiting low proliferation, thereby suggesting that these exceedingly rare lesions probably carry a favorable prognosis - although the scarce availability regarding descriptions of this tumor entity nevertheless might justify careful clinical monitoring and mandate investigations in larger case series.

Indexed as

Adenocarcinoma, FollicularAgedCarcinoma, Signet Ring CellCell NucleusDiagnosis, DifferentialHumansIodine RadioisotopesMaleMutationThyroid GlandThyroid NeoplasmsIodine RadioisotopesFollicular thyroid cancerPTENSignet ring cell

Identifiers

PMID31699114
PMCPMC6839064
OpenAlexW2988339617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.